Navigation Links

Biology Technology

Apiscent Labs Launches New Website

St. Francis, WI (PRWEB) November 23, 2014 Apiscent Labs, a privately held U.S. based manufacturer and supplier of fine chemical ingredients to the global pharmaceutical and flavor & fragrance industries announced the launch of its new website, The homepage welcomes visitors with a description of Apiscent Labs, clean design, easy navigation, rotating images... [Comments]

DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites

Audubon, PA and London (PRWEB) November 21, 2014 Two new educational webinars hosted by DrugDev in December will explore what comes next for ALS research and how the pharmaceutical industry can make life easier for clinical sites. After the Ice Bucket Challenge: Where Does the ALS Money Go? Featuring guest speaker Dr. Merit Cudkowicz Date: Tuesday, 2 December 2014 Time: 1:30p... [Comments]

Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund

Richmond, VA (PRWEB) November 21, 2014 During his lifetime Richard L. Sharp was a pioneering businessman who understood the need to surround himself with great people and take risks to achieve success. A visionary, CEO and entrepreneur, his friends often marveled at his extraordinarily courageous attitude when taking on challenges. That’s how he lived his life and -- even with his death imp... [Comments]

Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd

Boston, MA (PRWEB) November 21, 2014 Prominent academics, leaders of the biopharmaceutical industry and key investors will gather on December 3rd at Genetic Rx, a networking conference of the Boston Biotech Conferences series. GeneticRx will take place at the Joseph B. Martin Conference Center at Harvard Medical School and will discuss the present and future of genetic medicines—including s... [Comments]

CannLabs Secures $750,000 Line Of Credit

Denver, Colo. (PRWEB) November 21, 2014 CannLabs, Inc. (OTCQB: CANL), the leading provider of proprietary cloud based analytics and scientific testing methodologies relating to cannabis, today announced that it has received a commitment for a $750,000 line of credit from an existing stockholder of the Company. “We are extremely pleased to have secured this commitment from one of our e... [Comments]

RURO Announces Limfinity® version 5.1.4

Frederick, MD (PRWEB) November 21, 2014 RURO, Inc., a leading LIMS, RFID and sample management solutions provider, has released Limfinity® version 5.1.4. RURO’s deployment teams have been performing more installation projects of Limfinity® than ever in RURO’s 8 year history. Many deployments have included majority configuration and minority framework enhancement. Limfinity®... [Comments]

Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition

Chicago, IL (PRWEB) November 21, 2014 On November 17th Chicago start-up Briteseed outperformed 137 medical technology competitors at the 2014 Emerging Medical Technologies Summit in San Francisco to take first place in the MedTech Innovator Awards. Widely regarded among Silicon Valley investors and technology elites as the premier showcase for emerging medical device innovation, the win al... [Comments]

Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets

(PRWEB) November 22, 2014 The “Chiral Chromatography Columns Market by type (Empty, Pre-packed, Analytical, Preparative), by Material (Metal, Glass, Plastic), by Application [GC, LC (HPLC, UHPLC, Flash Chromatography, UFLC), TLC, SFC] - Forecast to 2018” analyses and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and Rest of the W... [Comments]

Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University

Grand Rapids, MI (PRWEB) November 22, 2014 Respiratory therapy students will soon have the opportunity to simulate the proper management of life-like respiratory ailments using the latest in training and test lung devices . Grand Rapids-based, Michigan Instruments Inc. developers of the world-renowned “Michigan Lung” plans to donate two of the respiratory simulation units to the pro-gram,... [Comments]

Viruses' Advantage of Surprise is Lost

LONDON , Nov. 21, 2014  The element of surprise has been a major advantage of viruses in emerging diseases, i.e., they strike without warning. Until now, epidemiologists had nothing to measure that might provide advance warning of a viral outbreak, resulting in suboptimal responses to both the H1N1 pandemic of 2009 and to Ebola currently. Photo - http://photos.prnewswi... [Comments]

KLOX Technologies meldet Neubesetzung von Führungspositionen

LAVAL, Quebec , November 21, 2014   Todd Martensen wechselt als Chief Commercial Officer zu KLOX    Mariano Rodriguez zum SVP der Unternehmensentwicklung und Chief Financial Officer bestellt    KLOX ist bestens vorbereitet, um in Europa mit der Vermarktung seines jüngst zugelassenen Behandlungssystems zur Wundheilung zu beginnen... [Comments]

Medicine Technology

Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference

HAYWARD, Calif. , Nov. 23, 2014 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), announced today that Paul F. Truex , President and Chief Executive Officer, will present a corporate update at the 2014 Annual Piper Jaffray Healthcare Conference. Anthera will present at 4:30PM ET, December 3 rd , at the Palace Hotel in New York City . About Anthera Pharmaceuticals An... [Comments]

Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules

DAYTON, N.J. , Nov. 23, 2014  Aurobindo Pharma USA is voluntarily recalling lot GESB14011-A of Gabapentin Capsules, USP 300 mg 100-count bottles to the consumer level. The product lot has been found to contain some empty capsules. Empty capsules could result in missed dose(s) of gabapentin resulting in adverse health consequences that could range from no effect, shor... [Comments]

Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment

RALEIGH, N.C. , Nov. 22, 2014  Sprout Pharmaceuticals today announced positive preliminary results from a Phase 1 driving study, which demonstrate that women treated with flibanserin up to 200 mg at bedtime had no next-day impairment of driving ability. The data were presented at the 20 th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America... [Comments]

Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting

MIAMI , Nov. 22, 2014  New data demonstrates that flibanserin, a novel, non-hormonal medicine being investigated for the most common form of female sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), does not impair next-day cognitive function or driving performance in premenopausal women when taken at bedtime. The data was presented at the Sexual Medicine Societ... [Comments]

CytoSorbents Wins Beacon of Light Award

MONMOUTH JUNCTION, N.J. , Nov. 21, 2014  CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® cytokine adsorber to treat critically-ill patients in multiple countries worldwide, was awarded the Beacon of Light Award at last night's New Jersey Tech Council Annual Awards Celebration. ... [Comments]

El 'seguimiento inteligente' consigue un excelente momento

NEWTOWN, Pennsylvania , 21 de noviembre de 2014  BioClinica®, Inc., un proveedor líder de servicios de ensayos clínicos externalizados y tecnologías eClinical, ha indicado un aumento de la demanda de su aproximación de 'seguimiento inteligente' para el seguimiento basado en el riesgo en los ensayos clínicos. El seguimiento inteligente ampl... [Comments]

Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants

LONG BEACH, Calif. , Nov. 21, 2014   Long Beach dentist , Dr. Rassouli, is now offering dental implants. Dental implants are often called the gold standard in tooth replacement because they offer the closest match to natural teeth. They are a stable, long-lasting way to restore and preserve smiles and improve overall dental health. Dr. Rassouli can use dental implants to r... [Comments]

Alarming Stats Show Holiday Drinking an Issue for Many

DENVER , Nov. 21, 2014 Statistics released from a number of organizations show that binge drinking and drunk driving increase astronomically during the holidays, beginning with Thanksgiving eve, which is now termed "Blackout Wednesday" in many cities. The data, highlighted in an Infographic released by Alcohol Monitoring Systems as part of their annual Sober Days for t... [Comments]

CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales

ORLANDO, Fla. , Nov. 21, 2014 MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on April 4, 2014 reported nine months and the 3 rd quarter sales ended September 30, 2014 of $8.7 million and $2.8 million. Operating income was $448,000 for the nine months ended September 2014 and a $38,000 loss for the quarter ended September 2014. "Even though our 3 rd quarter is usually... [Comments]

Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring

BETHLEHEM, Pa. , Nov. 21, 2014  Particle Sciences, Inc (PSI), the leading CDMO for drug eluting devices, has developed and manufactured a new innovative vaginal ring for Ladee Pharma Research Institute (LPRI), the Research and Development arm of Exeltis Pharmaceuticals.  According to Bruce Frank , Vice President of Project Management at Particle Sciences, "This vagin... [Comments]

China Recombinant Protein Drug Industry Report, 2014-2017

DUBLIN , Nov. 21, 2014 Research and Markets  has announced the addition of the "China Recombinant Protein Drug Industry Report, 2014-2017" report to their offering. The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like.... [Comments]

(Date:11/22/2014)... CannLabs, Inc. (OTCQB: CANL), the leading ... methodologies relating to cannabis, today announced that it has ... from an existing stockholder of the Company. , ... from one of our existing stockholders,” stated Mark ... help accelerate our planned expansions into the Connecticut and ...
(Date:11/22/2014)... , Nov. 21, 2014  The element of ... emerging diseases, i.e., they strike without warning. Until now, ... warning of a viral outbreak, resulting in suboptimal responses ... Ebola currently. Photo - ... has now been removed because virus gene structural changes ...
(Date:11/21/2014)... Diego, CA (PRWEB) November 20, 2014 ... extended their Sartorius Entris Balance promotion . The ... customers seeking a durable, high accuracy, and easy-to-maintain balance ... made in Germany. It was designed to help customer’s ... affordable and a balance that is very durable. Sartorius ...
(Date:11/21/2014)... Fayetteville, Arkansas (PRWEB) November 20, 2014 ... partners, Pinnacle Ozone Solutions, LLC (Pinnacle), and PCI, ... equipment, announced that they have been selected to ... City of Fayetteville, Arkansas Paul R. Noland Wastewater ... feature BlueInGreen’s patented HyDOZ® gas dissolution ...
Breaking Biology Technology:CannLabs Secures $750,000 Line Of Credit 2Viruses' Advantage of Surprise is Lost Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4
... CA (March 14, 2012): A highly targeted bactericidal ... O104 strain was rapidly created using AvidBiotics, antibacterial Purocin ... draft genomic sequence data as detailed in a new ... described offers a rapid-response platform with the potential to ...
... United Nations (UN) global carbon market requires substantial reform because ... it is meant to help, according to new research from ... research findings are released as the UN, which has designated ... a policy dialogue about its Clean Development Mechanism (CDM), under ...
... RICHLAND, Wash. -- A study that examines a ... of how they function and how repeated use ... clues to why this material performs better than ... higher than conventional lithium battery electrodes, silicon-carbon nanocomposite ...
Cached Biology Technology:Targeted antibacterial agent rapidly created in response to serious food safety pathogen 2Targeted antibacterial agent rapidly created in response to serious food safety pathogen 3UN emission market needs urgent reform 2Silicon-carbon electrodes snap, swell, don't pop 2Silicon-carbon electrodes snap, swell, don't pop 3Silicon-carbon electrodes snap, swell, don't pop 4
(Date:11/22/2014)... , Nov. 21, 2014 Research and Markets ... Protein Drug Industry Report, 2014-2017" report to their ... The Chinese recombinant protein drug market has been ... consumption ability and the like. During 2005-2013, sales of ... at a CAGR of 19.1%, and it is projected ...
(Date:11/21/2014)... Nov. 21, 2014  Alere Inc. (NYSE: ... has appointed Juliet Cunningham as Vice President, ... be responsible for driving communications with the investment community. ... series of changes to increase shareholder value, it is ... said Namal Nawana, Chief Executive Officer. "We are delighted ...
(Date:11/21/2014)... VIENNA, Va. , Nov. 21, 2014  Alta ... in Southern California , today announced ... technology. Alta will be providing the innovative BeClose system ... Logo - ... providing the kind of affordable 24/7 care our clients ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2
... Fund,s Third Investment in Vaccine to Prevent Rotavirus, ... Healthcare today,announced that it has purchased a royalty ... Rotarix(R) is an oral,vaccine developed to prevent rotavirus ... dehydration in infants and young children.,The product is ...
... YORK, Jan. 23 The Public Patent,Foundation ("PUBPAT") announced ... four key HIV/AIDS drug patents held by Gilead Sciences,that ... fumarate,(TDF), a key weapon in the battle against HIV/AIDS. ... name VIREAD and as a part of its ATRIPLA,combination ...
Cached Medicine Technology:Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix(R) 2U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims 2